Transepithelial resistance of NHBE decreases significantly after PAA exposure. حسب Ellie S. Burns (21246537)

Cephalometric measurement points. حسب Lijuan Liu (136685)

الموضوعات:

Comparison of PCNA expression grades across different groups at various time points. حسب Jian-feng Li (8667645)

الموضوعات:

Determination of the ventilatory threshold (VT) point. حسب Kazufumi Hisamoto (21416905)

الموضوعات:

Comparison of mTOR expression grading among different groups at different time points. حسب Jian-feng Li (8667645)

الموضوعات:

Comparison of renal tissue pathological damage grades across different groups at all time points. حسب Jian-feng Li (8667645)

الموضوعات:

Blocking SLAMF5 significantly delayed the onset of the disease and reduced its severity. حسب Laura Bellassen (22209109)

Effect of 1.25(OH)₂D₃ treatment on proteinuria at different time points after the induction of glomerulonephritis. حسب Jian-feng Li (8667645)

الموضوعات:

RTA408 significantly reduces RGCs loss. حسب Hongmei Qian (538647)

الموضوعات:

Sampling point (Source: حسب Yonggang Huang (223155)

S1 Dataset - حسب Yue He (385239)

الموضوعات:

Schematic diagram of FlexiVent lung function detection. حسب Yue He (385239)

الموضوعات:

Changes in lung function of mice exposed to continuous inhalation of CS. حسب Yue He (385239)

الموضوعات:

Changes in sRAGE levels in BALF after 120 consecutive days of CS exposure. حسب Yue He (385239)

الموضوعات:

Pathological changes in lung tissue of mice exposed to continuous inhalation of CS. حسب Yue He (385239)

الموضوعات:

Changes in inflammatory cell count in BALF of mice exposed to continuous CS inhalation. حسب Yue He (385239)

الموضوعات:

Correlation between sRAGE levels and pulmonary dysfunction and inflammatory response in CS exposed 120 day group mice. حسب Yue He (385239)

الموضوعات:

Changes in the expression of inflammatory cytokines in BALF of mice exposed to continuous CS inhalation. حسب Yue He (385239)

الموضوعات:

Comparison of body weight gain between control group and cigarette smoke exposed group mice. حسب Yue He (385239)

الموضوعات:

Primary and secondary efficacy end points (intention-to-treat population). حسب Benjamin R. Lewis (22279166)

الموضوعات: